Published in J Antimicrob Chemother on February 01, 1987
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrob Agents Chemother (1992) 0.92
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. Antimicrob Agents Chemother (1991) 0.88
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2006) 0.82
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis. Antimicrob Agents Chemother (1994) 0.82
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 0.81
New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother (1989) 5.49
Pasteurella multocida bacteremia: report of thirteen cases over twelve years and review of the literature. Scand J Infect Dis (1987) 2.47
Why is antimicrobial de-escalation under-prescribed for urinary tract infections? Infection (2012) 2.04
Inactivation of Mycobacterium tuberculosis for DNA typing analysis. J Clin Microbiol (1999) 1.94
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother (2000) 1.43
Bacteremia due to Dietzia maris in an immunocompromised patient. Clin Infect Dis (1999) 1.40
[Appropriate use of antibiotics in hospitals. Investigating clinical practices in management of community-acquired pneumonia]. Presse Med (2005) 1.39
[Treatment of exacerbations of chronic obstructive pulmonary disease with pristinamycin]. Rev Mal Respir (2004) 1.38
Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother (1990) 1.35
Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res (2000) 1.12
In vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol (1998) 1.08
Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother (1997) 1.04
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis. Int J Antimicrob Agents (2010) 1.04
Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob Agents Chemother (1994) 1.04
Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis (1993) 1.03
Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol (1986) 1.02
Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin. J Antimicrob Chemother (1999) 0.98
Recurrent pneumonia due to rifampicin-resistant Rhodococcus equi in a patient infected with HIV. J Infect (1992) 0.95
Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. J Biomed Mater Res (2000) 0.95
In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model. J Antimicrob Chemother (2001) 0.93
Assessment of formulas for calculating critical concentration by the agar diffusion method. Antimicrob Agents Chemother (1987) 0.93
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrob Agents Chemother (1992) 0.92
Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. Antimicrob Agents Chemother (1996) 0.92
Comparison of phenotypic methods and DNA hybridization for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1994) 0.91
Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res (2003) 0.90
Diagnosis of extrapulmonary tuberculosis by a commercial polymerase chain reaction kit. Pathol Biol (Paris) (1998) 0.89
Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex. J Antimicrob Chemother (2000) 0.88
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. Antimicrob Agents Chemother (1991) 0.88
[Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin]. Pathol Biol (Paris) (1987) 0.88
A case of biliary tract infection caused by Haemophilus parainfluenzae. Eur J Clin Microbiol Infect Dis (1992) 0.87
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med (1993) 0.87
Actinomycosis of the gallbladder due to Actinomyces naeslundii. J Infect (1987) 0.86
A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment. Eur J Clin Microbiol Infect Dis (2012) 0.84
[Bactericidal activity of antibiotics as a function of pharmacokinetic constants. II. Effect of pharmacokinetic parameters (C max and Ke) on the bactericidal activity of gentamicin]. Pathol Biol (Paris) (1982) 0.84
[Prior use of anti-inflammatory and antibiotic drugs in patients hospitalized for peritonsillar abscess]. Med Mal Infect (2009) 0.84
Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Antimicrob Agents Chemother (2002) 0.83
Therapeutic amoxicillin levels achieved with oral administration in term neonates. Eur J Clin Pharmacol (2007) 0.83
Almond oil implicated in a Staphylococcus capitis outbreak in a neonatal intensive care unit. J Perinatol (2007) 0.83
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints. Eur J Clin Microbiol Infect Dis (2010) 0.83
[Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)]. Ann Microbiol (Paris) (1979) 0.83
In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrob Agents Chemother (1996) 0.82
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis. Antimicrob Agents Chemother (1994) 0.82
[Bactericidal activity of aminosides in a static system and in a dynamic model]. Nouv Presse Med (1979) 0.81
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. J Antimicrob Chemother (1997) 0.81
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 0.81
The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. J Antimicrob Chemother (1996) 0.81
[Susceptibility of Campylobacter pyloridis to antibiotics]. Pathol Biol (Paris) (1987) 0.81
A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit. Lett Appl Microbiol (2011) 0.81
Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter? Eur J Clin Microbiol Infect Dis (2014) 0.81
[Expression of staphylococci resistance to oxacillin and cefalotin ]. Pathol Biol (Paris) (1982) 0.80
Who are the carriers of MRSA in the community? A prospective study in the Pays de la Loire region of France. Clin Microbiol Infect (2009) 0.80
Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. Eur J Clin Microbiol Infect Dis (1989) 0.80
[Bactericidal effect of piperacillin alone and combined]. Presse Med (1986) 0.80
[Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers]. Pathol Biol (Paris) (1991) 0.79
Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both. J Antimicrob Chemother (1995) 0.79
Non-tuberculous mycobacterial tenosynovitis. Lancet (1990) 0.79
Risk factors and pathogens involved in early ventilator-acquired pneumonia in patients with severe subarachnoid hemorrhage. Eur J Clin Microbiol Infect Dis (2013) 0.78
Large discrepancies in linezolid use between French teaching hospitals: A comment on "Antimicrobial stewardship and linezolid". Int J Clin Pharm (2015) 0.78
Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007). Med Mal Infect (2009) 0.78
[Bactericidal effect of daptomycin (LY 146032) compared with vancomycine and teicoplanin against gram-positive bacteria]. Pathol Biol (Paris) (1989) 0.78
The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. Eur J Clin Microbiol Infect Dis (2012) 0.77
Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis (2011) 0.77
[Community-acquired pneumonia caused by Staphylococcus aureus in non-HIV infected adult patients]. Rev Pneumol Clin (1999) 0.77
A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm. Eur J Clin Microbiol Infect Dis (2014) 0.77
In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints. Int J Antimicrob Agents (2011) 0.77
Pharmacokinetics and pharmacodynamics of two oral forms of cefuroxime axetil. Fundam Clin Pharmacol (1997) 0.77
Effect of maternal antibiotic treatment on fetal periventricular white matter cell death in a rabbit intrauterine infection model. Acta Paediatr (2003) 0.77
[Syphilis in Nantes tertiary care hospital between 2000 and 2010: a case series of 36 hospitalized patients]. Rev Med Interne (2013) 0.76
[Bactericidal activity of antibiotics as a function of pharmacokinetic constants. I. Experimental dynamic model simulating variations in the concentrations of antibiotics]. Pathol Biol (Paris) (1982) 0.76
Pharmacokinetics of norfloxacin in the elderly. Fundam Clin Pharmacol (1991) 0.76
Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits. J Pharmacol Exp Ther (2011) 0.76
A new approach to optimal antibiotic dosage regimen by coupling pharmacokinetics and killing curve parameters. Methods Find Exp Clin Pharmacol (1990) 0.76
In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model. Antimicrob Agents Chemother (2009) 0.76
[Theoretical bases for the combination of ceftazidime with other antibiotics. Synergism research]. Presse Med (1988) 0.75
[Non 01 Vibrio cholerae septicemia]. Presse Med (1989) 0.75
[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation]. Presse Med (1995) 0.75
Teaching individualized antibiotic dosage regimens by means of two computer-assisted learning programs. Int J Biomed Comput (1994) 0.75
[Kinetics of pefloxacin diffusion in human bone tissue following a single infusion of 800 mg. Evaluation of an extraction technic using chloroform]. Pathol Biol (Paris) (1988) 0.75
[In vivo activity of amoxicillin in a non-toxigenic Corynebacterium diphtheriae rabbit endocarditis experimental model]. Pathol Biol (Paris) (2002) 0.75
[Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin]. Pathol Biol (Paris) (1991) 0.75
[Experimental Enterobacter cloacae endocarditis treated with gentamicin. Predictive value of the in vitro bactericidal rate]. Pathol Biol (Paris) (1988) 0.75
Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo. Eur J Clin Microbiol Infect Dis (1997) 0.75